StemCell Institute Inc.
7096.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥13,898 | ¥19,264 | ¥25,770 | ¥20,333 |
| - Cash | ¥3,201 | ¥2,846 | ¥3,324 | ¥3,511 |
| + Debt | ¥519 | ¥11 | ¥7 | ¥0 |
| Enterprise Value | ¥11,216 | ¥16,429 | ¥22,453 | ¥16,822 |
| Revenue | ¥2,679 | ¥2,481 | ¥2,091 | ¥1,782 |
| % Growth | 8% | 18.6% | 17.4% | – |
| Gross Profit | ¥1,692 | ¥1,576 | ¥1,336 | ¥1,111 |
| % Margin | 63.2% | 63.5% | 63.9% | 62.4% |
| EBITDA | ¥695 | ¥534 | ¥402 | ¥309 |
| % Margin | 25.9% | 21.5% | 19.2% | 17.4% |
| Net Income | ¥386 | ¥311 | ¥198 | ¥134 |
| % Margin | 14.4% | 12.5% | 9.5% | 7.5% |
| EPS Diluted | 37.67 | 30.25 | 19.33 | 13.2 |
| % Growth | 24.5% | 56.5% | 46.4% | – |
| Operating Cash Flow | ¥468 | ¥335 | ¥100 | ¥469 |
| Capital Expenditures | -¥478 | -¥202 | -¥60 | -¥204 |
| Free Cash Flow | -¥10 | ¥133 | ¥40 | ¥265 |